Stockreport

Immix Biopharma Announces Proposed Public Offering of Common Stock

Immix Biopharma, Inc.  (IMMX) 
PDF LOS ANGELES, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (the “Company”), a clinical-stage biopharmaceutical company trailblazing cell thera [Read more]